Katja B. Zimmer, Arne Gessner, Dennis Kannenkeril, Agnes Bosch, Armin Ströbel, Roland E. Schmieder et al. Effects of SGLT‐2 Inhibitors on Plasma Concentrations and Renal Clearance of the Risk Marker Trimethylamine‐N‐Oxide in Patients With Type‐2 Diabetes. // Endocrinology, Diabetes and Metabolism. – 2026. – DOI: 10.1002/edm2.70318. – URL: https://onlinelibrary.wiley.com/doi/10.1002/edm2.70318?af=R
Katja B. Zimmer, Arne Gessner, Dennis Kannenkeril, Agnes Bosch, Armin Ströbel, Roland E. Schmieder, & Renke Maas (2026). Effects of SGLT‐2 Inhibitors on Plasma Concentrations and Renal Clearance of the Risk Marker Trimethylamine‐N‐Oxide in Patients With Type‐2 Diabetes. Endocrinology, Diabetes and Metabolism. https://doi.org/10.1002/edm2.70318
Katja B. Zimmer, et al. “Effects of SGLT‐2 Inhibitors on Plasma Concentrations and Renal Clearance of the Risk Marker Trimethylamine‐N‐Oxide in Patients With Type‐2 Diabetes.” Endocrinology, Diabetes and Metabolism, 2026. doi:10.1002/edm2.70318.
@article{Zimmer2026,
title = {Effects of SGLT‐2 Inhibitors on Plasma Concentrations and Renal Clearance of the Risk Marker Trimethylamine‐N‐Oxide in Patients With Type‐2 Diabetes},
author = {Zimmer, Katja B. and Gessner, Arne and Kannenkeril, Dennis and Bosch, Agnes and Ströbel, Armin and Schmieder, Roland E. and Maas, Renke},
journal = {Endocrinology, Diabetes and Metabolism},
year = {2026},
doi = {10.1002/edm2.70318},
url = {https://onlinelibrary.wiley.com/doi/10.1002/edm2.70318?af=R}
}